SEC Form 4 · accession 0001209191-17-042522
ACHILLION PHARMACEUTICALS INC · ACHN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Jason S Fisherman
Director
Period of report
Jun 28, 2017
Accepted (ET)
Jun 30, 2017 · 4:28 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001070336
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Jun 28, 2017 | W | 1,500 | $0.00 | A | 1,500 | I | Inherited IRA |
| Common Stock | holding | — | — | — | 50,000 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares represent inherited shares that are held in an inherited IRA.